Staar Surgical Co

STAA Nasdaq SEC CIK 718937
Follow Staar Surgical Weekly email: filings, results

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$239.4M−$80.4M
FY25$313.9M−$20.2M
FY24$322.4M$21.3M
FY23$239.4M$39.7M
FY22$230.5M$27.5M
FY21$22.1M$5.9M
FY20$20.9M$14M
FY19$22.9M$5M
FY18$22.3M−$2.1M
FY17$23.3M−$12.1M
FY16$77.1M−$6.5M
FY15$75M−$8.4M
FY14$72.2M$398K
FY13$63.8M−$1.8M
FY12$62.8M$1.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2676.2%−38.3%−33.6%
FY2576.3%−4%−6.4%
FY2478.4%8.7%6.6%
FY2393.3%18.3%16.6%
FY2277.5%14.5%11.9%
FY21−104.5%30.7%26.8%
FY20−83.2%56.8%67.3%
FY19−41.9%28.8%21.7%
FY18−18.2%−16.3%−9.6%
FY17−3.2%−54.3%−52%
FY1668.4%−6.9%−8.5%
FY1565.1%−10.7%−11.2%
FY1469.7%1%0.6%
FY1369.4%−1.9%−2.8%
FY1267.5%4.4%2.1%
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0$20M$40MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26−$40.1M
FY25−$7.7M
FY24−$3.6M
FY23$17.6M
FY22$30.3M
FY21$12.5M
FY20$15.7M
FY19$10.5M
FY18$1.8M
FY17−$2.2M
FY16−$4.2M
FY15−$12M
FY14−$93K
FY13$946K
FY12$4.4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Staar Surgical
  • Healthcare median
−100%−50%0%50%100%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearStaar SurgicalHealthcare median
FY26−33.6%−11.1%
FY25−6.4%−30.6%
FY246.6%−47%
FY2316.6%−58%
FY2211.9%−80.4%
FY2126.8%−71.9%
FY2067.3%−62.2%
FY1921.7%−46.3%
FY18−9.6%−49.6%
FY17−52%−45.9%
FY16−8.5%−36%
FY15−11.2%−38.4%
FY140.6%−35.5%
FY13−2.8%−37.1%
FY122.1%−29.1%